Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announces that it has entered into a definitive agreement to acquire Robocath, a venture-backed innovator of robotic technologies for interventional cardiology and neurointerventions. This acquisition significantly strengthens Stereotaxis’ position as a leading platform for the full spectrum of endovascular procedures, combining complementary technologies to deliver next-generation fully-integrated robotic solutions for electrophysiology, interventional cardiology and neurointerventions.
Read the full article: Stereotaxis Announces Definitive Agreement to Acquire Robocath //
Source: https://www.globenewswire.com/news-release/2026/04/15/3274290/21634/en/Stereotaxis-Announces-Definitive-Agreement-to-Acquire-Robocath.html